Receptor activator of NF-κB (RANK) and RANK ligand protein expression in invasive ductal carcinoma

被引：0
|
作者：
Roudier-Meyer, M.
Jacob, A.
Tometsko, M.
Erwert, R.
Woody, L.
Soriano, R.
Huang, L. Y.
Hawkins, J.
Branstetter, D.
Dougall, W.
机构：
[1] Amgen Inc, Seattle, WA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：173S / 173S
页数：1
相关论文
共 50 条
  • [31] Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
    Clar, Kim L.
    Weber, Lisa M.
    Schmied, Bastian J.
    Heitmann, Jonas S.
    Marconato, Maddalena
    Tandler, Claudia
    Schneider, Pascal
    Salih, Helmut R.
    CANCERS, 2021, 13 (23)
  • [32] Efficacy of a genetically engineered soluble receptor activator of NF-κB (RANK) fusion protein on bone resorption in vitro and in vivo.
    Oyajobi, BO
    Williams, PJ
    Traianedes, K
    Yoneda, T
    Anderson, DM
    Mundy, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S163 - S163
  • [33] Bone Resorption Control of Tooth Eruption and Root Morphogenesis: Involvement of the Receptor Activator of NF-κB (RANK)
    Castaneda, Beatriz
    Simon, Yohann
    Jacques, Jaime
    Hess, Estelle
    Choi, Yong-Wong
    Blin-Wakkach, Claudine
    Mueller, Christopher
    Berdal, Ariane
    Lezot, Frederic
    JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (01) : 74 - 85
  • [34] The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
    Vega, Damaris
    Maalouf, Naim M.
    Sakhaee, Khashayar
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4514 - 4521
  • [35] The high rate of bone resorption in multiple myeloma is due to RANK (Receptor Activator of Nuclear Factor-κB) and RANK ligand expression
    Roux, S
    Mariette, X
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1111 - 1118
  • [36] Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast
    Bai, XC
    Lu, D
    Liu, AL
    Zhang, ZM
    Li, XM
    Zou, ZP
    Zeng, WS
    Cheng, BL
    Luo, SQ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 17497 - 17506
  • [37] Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-κB (NF-κB) ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvarial bones
    Swanson, Charlotte
    Lorentzon, Mattias
    Conaway, H. Herschel
    Lerner, Ulf H.
    ENDOCRINOLOGY, 2006, 147 (07) : 3613 - 3622
  • [38] Vector-averaged gravity regulates gene expression of receptor activator of NF-κB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway
    Kanematsu, M
    Yoshimura, K
    Takaoki, M
    Sato, A
    BONE, 2002, 30 (04) : 553 - 558
  • [39] RANK and RANK Ligand (RANKL) Expression in Invasive Breast Carcinoma and Human Breast Cancer Cell Lines
    Jacob, A.
    Branstetter, D.
    Rohrbach, K.
    Winters, A.
    Erwert, R.
    Allred, S.
    Jones, J.
    Miller, R.
    Tometsko, M.
    Blake, M.
    Dougall, W. C.
    CANCER RESEARCH, 2011, 71
  • [40] Autoantibodies to receptor activator of NF-kB (RANK).
    Kato, T
    Yao, ZY
    Matsui, T
    Kurokawa, M
    Sekine, T
    Nishioka, K
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S75 - S75
12345